Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
PharmaCyte Biotech Inc
Swot
PharmaCyte Biotech Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
PharmaCyte Biotech Inc has 8 Strengths, 16 Weaknesses, 2 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(8)
Weakness
(16)
Opportunity
(2)
Threats
(2)
Others
(0)
Significant (over 30%) distance from 52 week high
PE less than Industry PE
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Affordable Stocks - Stocks with Good Trendlyne Valuation Score
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Stock with Low PE (PE < = 10)
Negative Breakdown First Support (LTP < S1)
Stocks with Quarter Change % less than Industry
New 52 week low today
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Oversold by Money Flow Index (MFI)
Highest fall from 52 Week High
Top Losers
Negative Breakdown First Support (LTP < S1)
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Declining profits every quarter for the past 2 quarters
RSI indicating price weakness
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Red Flags: Weakening Technicals and Share Price Decline
Institutions decreased their shareholding last quarter
